Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W H Chan

Showing results (411-420 of 424) with videos related to

Pageof 43
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2012
Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research GroupWinnie Yeo, Hyun C Chung, Stephen L Chan, et al.
The Journal of Pathology|December 13, 2017
EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinomaRaymond W-M Lung, Pok-Man Hau, Ken H-O Yu, et al.
Cancer|May 7, 2015
Clinical utility of plasma Epstein-Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinomaEdwin P Hui, Brigette B Y Ma, K C Allen Chan, et al.
Nature Communications|December 8, 2018
An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinomaHanyong Sun, Weiqin Yang, Yuan Tian, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 7, 2019
"Interchangeability" of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracyEmina Torlakovic, Hyun J Lim, Julien Adam, et al.
Ocular Immunology and Inflammation|December 6, 2023
Systemic Involvement in Immunoglobulin G4-Related Ophthalmic DiseaseKenneth K H Lai, Fatema Mohamed Ali Abdulla Aljufairi, Jake Uy Sebastian, et al.
American Journal of Ophthalmology|August 6, 2023
Ocular Surface Evaluation in Immunoglobulin G4-Related Ophthalmic DiseaseKenneth K H Lai, Xulin Liao, Fatema Mohamed Ali Abdulla Aljufairi, et al.
Hepatology (Baltimore, Md.)|November 8, 2019
Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response-Based ApproachGuohong Han, Sarah Berhane, Hidenori Toyoda, et al.
Gut|April 5, 2023
Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinomaZhewen Xiong, Stephen Lam Chan, Jingying Zhou, et al.
Cellular & Molecular Immunology|May 20, 2022
Aberrant cholesterol metabolic signaling impairs antitumor immunosurveillance through natural killer T cell dysfunction in obese liverWenshu Tang, Jingying Zhou, Weiqin Yang, et al.
Pageof 43

Showing results (411-420 of 424) with videos related to

Sort By:
Pageof 43
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2012
Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research GroupWinnie Yeo, Hyun C Chung, Stephen L Chan, et al.
The Journal of Pathology|December 13, 2017
EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinomaRaymond W-M Lung, Pok-Man Hau, Ken H-O Yu, et al.
Cancer|May 7, 2015
Clinical utility of plasma Epstein-Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinomaEdwin P Hui, Brigette B Y Ma, K C Allen Chan, et al.
Nature Communications|December 8, 2018
An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinomaHanyong Sun, Weiqin Yang, Yuan Tian, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 7, 2019
"Interchangeability" of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracyEmina Torlakovic, Hyun J Lim, Julien Adam, et al.
Ocular Immunology and Inflammation|December 6, 2023
Systemic Involvement in Immunoglobulin G4-Related Ophthalmic DiseaseKenneth K H Lai, Fatema Mohamed Ali Abdulla Aljufairi, Jake Uy Sebastian, et al.
American Journal of Ophthalmology|August 6, 2023
Ocular Surface Evaluation in Immunoglobulin G4-Related Ophthalmic DiseaseKenneth K H Lai, Xulin Liao, Fatema Mohamed Ali Abdulla Aljufairi, et al.
Hepatology (Baltimore, Md.)|November 8, 2019
Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response-Based ApproachGuohong Han, Sarah Berhane, Hidenori Toyoda, et al.
Gut|April 5, 2023
Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinomaZhewen Xiong, Stephen Lam Chan, Jingying Zhou, et al.
Cellular & Molecular Immunology|May 20, 2022
Aberrant cholesterol metabolic signaling impairs antitumor immunosurveillance through natural killer T cell dysfunction in obese liverWenshu Tang, Jingying Zhou, Weiqin Yang, et al.
Pageof 43